Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma
/in International Publications, Malignant MelanomaImmunotherapy opportunities in ovarian cancer
/in Dendritic Cells, International Publications, Ovarian CancerDendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid CancerImmunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond
/in International Publications, Malignant Lymphoma[Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells]
/in Breast Cancer, International PublicationsNeoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?
/in International Publications, Soft Tissue SarcomaAn effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells
/in Colorectal Cancer, International PublicationsA phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
/in International Publications, Malignant Melanoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer